title: Stereotactic radiation and checkpoint inhibitors in melanoma patients with BM: a question of drug, timing or both?
authors.affiliation: Department of Radiation Oncology and DITEP, Gustave Roussy, University Hospital, Université Paris-Saclay, INSERM 1030 Molecular Radiotherapy, Villejuif, France frederic.dhermain@gustaveroussy.fr.
authors.forename: F
authors.initials: F
authors.lastname: Dhermain
authors.affiliation: Department of Radiation Oncology and DITEP, Gustave Roussy, University Hospital, Université Paris-Saclay, INSERM 1030 Molecular Radiotherapy, Villejuif, France.
authors.forename: E
authors.initials: E
authors.lastname: Deutsch
mesh_terms: D006801:Humans; D008545:Melanoma / Q000601:surgery*; D016634:Radiosurgery